BioLineRx Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BLRX Nasdaq 2836 www.biolinerx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioLineRx Ltd.

BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... - Nov 28th, 2025 6:00 pm
BLRX: Stem Cell Mobilization Presentation at ASH - Nov 25th, 2025 8:09 am
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Nov 24th, 2025 5:00 am
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025 - Nov 18th, 2025 5:00 am
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types - Nov 17th, 2025 5:00 am
BLRX: A Venture into GBM - Sep 30th, 2025 6:46 am
BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers - Sep 29th, 2025 5:00 am
BLRX: ASCO Poster & Abstract - Aug 15th, 2025 9:56 am
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Aug 14th, 2025 5:00 am
BioLineRx to Report Second Quarter 2025 Results on August 14, 2025 - Aug 7th, 2025 5:00 am
H.C. Wainwright Reaffirms Buy on BioLineRx Ltd. (BLRX) After ASCO 2025 - Jul 2nd, 2025 8:04 pm
BioLineRx upgraded to Buy from Hold at JonesResearch - May 31st, 2025 6:46 am
Why Is Nano-Cap BioLineRx Stock Surging On Friday? - May 30th, 2025 11:58 am
BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting - May 30th, 2025 5:00 am
BLRX: First Quarter Results - May 28th, 2025 3:38 am
BioLine Rx Ltd (BLRX) Q1 2025 Earnings Call Highlights: Transformational Moves and Financial ... - May 28th, 2025 1:04 am
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 27th, 2025 5:00 am
BioLineRx to Report First Quarter 2025 Results on May 27, 2025 - May 20th, 2025 5:00 am
BLRX: 2024 Financial Results - Apr 3rd, 2025 4:12 am
BioLine Rx Ltd (BLRX) Q4 2024 Earnings Call Highlights: Strategic Licensing and Market ... - Apr 2nd, 2025 3:00 pm